Old	New	Differences
1	1
2	2
3	3
4	4	Req. No. 264 Page 1 1
5	5	2
6	6	3
7	7	4
8	8	5
9	9	6
10	10	7
11	11	8
12	12	9
13	13	10
14	14	11
15	15	12
16	16	13
17	17	14
18	18	15
19	19	16
20	20	17
21	21	18
22	22	19
23	23	20
24	24	21
25	25	22
26	26	23
27	27	24
28	28	1
29	29	2
30	30	3
31	31	4
32	32	5
33	33	6
34	34	7
35	35	8
36	36	9
37	37	10
38	38	11
39	39	12
40	40	13
41	41	14
42	42	15
43	43	16
44	44	17
45	45	18
46	46	19
47	47	20
48	48	21
49	49	22
50	50	23
51	51	24
52	52
53	53	STATE OF OKLAHOMA
54	54
55	55	1st Session of the 59th Legislature (2023)
56	56
57	57	SENATE BILL 295 By: McCortney
58	58
59	59
60	60
61	61
62	62
63	63	AS INTRODUCED
64	64
65	65	An Act relating to controlled dangerous su bstances;
66	66	amending 63 O.S. 2021, Section 2-309D, as amended by
67	67	Section 2, Chapter 69, O.S.L. 2022 (63 O.S. Supp.
68	68	2022, Section 2-309D), which relates to c entral
69	69	repository information ; requiring the Oklahoma State
70	70	Bureau of Narcotics and Dangerous Drugs Control to
71	71	establish certain procedures; directing the Bureau to
72	72	revise certain inaccurate inf ormation; requiring
73	73	certain description and inclusion of infor mation; and
74	74	providing an effecti ve date.
75	75
76	76
77	77
78	78
79	79	BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA :
80	80	SECTION 1. AMENDATORY 63 O.S. 2021, Section 2 -309D, as
81	81	amended by Section 2, Chapter 69, O.S.L. 2022 (63 O.S. Supp. 2022,
82	82	Section 2-309D), is amended to read as follows:
83	83	Section 2-309D. A. The information collected at the cent ral
84	84	repository pursuant to the Anti-Drug Diversion Act shall be
85	85	confidential and shall no t be open to the public. Access to the
86	86	information shall be limited to:
87	87	1. Peace officers certified pursuant to Section 3311 of Title
88	88	70 of the Oklahoma Statutes who are employed as investigative agents
89	89
90	90
91	91	Req. No. 264 Page 2 1
92	92	2
93	93	3
94	94	4
95	95	5
96	96	6
97	97	7
98	98	8
99	99	9
100	100	10
101	101	11
102	102	12
103	103	13
104	104	14
105	105	15
106	106	16
107	107	17
108	108	18
109	109	19
110	110	20
111	111	21
112	112	22
113	113	23
114	114	24
115	115	1
116	116	2
117	117	3
118	118	4
119	119	5
120	120	6
121	121	7
122	122	8
123	123	9
124	124	10
125	125	11
126	126	12
127	127	13
128	128	14
129	129	15
130	130	16
131	131	17
132	132	18
133	133	19
134	134	20
135	135	21
136	136	22
137	137	23
138	138	24
139	139
140	140	of the Oklahoma State Bureau of Narcotics and Dange rous Drugs
141	141	Control;
142	142	2. The United State s Drug Enforcement Administration Diversion
143	143	Group Supervisor;
144	144	3. The executive di rector or chief investigator, as designated
145	145	by each board, of the following state boards:
146	146	a. Board of Podiatric Medical Examine rs,
147	147	b. Board of Dentistry,
148	148	c. Board of Pharmacy,
149	149	d. State Board of Medical Licensure and Supervision,
150	150	e. State Board of Osteopathic Exami ners,
151	151	f. State Board of Veterinary Medical Examiners,
152	152	g. Oklahoma Health Care Authority,
153	153	h. Department of Mental Health and Su bstance Abuse
154	154	Services,
155	155	i. Board of Examiners in Optometry,
156	156	j. Oklahoma Board of Nursing,
157	157	k. Office of the Chief Medical Examiner, and
158	158	l. State Board of Health;
159	159	4. A multicounty grand jury properly convened pursuant to the
160	160	Multicounty Grand Jury Act;
161	161	5. Medical practitioners employed by the Unite d States
162	162	Department of Veterans Affairs, the United States Military, or other
163	163	federal agencies treating patients in this state;
164	164
165	165
166	166	Req. No. 264 Page 3 1
167	167	2
168	168	3
169	169	4
170	170	5
171	171	6
172	172	7
173	173	8
174	174	9
175	175	10
176	176	11
177	177	12
178	178	13
179	179	14
180	180	15
181	181	16
182	182	17
183	183	18
184	184	19
185	185	20
186	186	21
187	187	22
188	188	23
189	189	24
190	190	1
191	191	2
192	192	3
193	193	4
194	194	5
195	195	6
196	196	7
197	197	8
198	198	9
199	199	10
200	200	11
201	201	12
202	202	13
203	203	14
204	204	15
205	205	16
206	206	17
207	207	18
208	208	19
209	209	20
210	210	21
211	211	22
212	212	23
213	213	24
214	214
215	215	6. At the discretion of the Director of the Oklahoma State
216	216	Bureau of Narcotics and D angerous Drugs Control, medical
217	217	practitioners and their staff including those employed by the
218	218	federal government in this state ; and
219	219	7. The members of the Op ioid Overdose Fatality Rev iew Board for
220	220	the purpose of carrying out the duties prescribed by Sectio n 2-1001
221	221	of this title.
222	222	B. This section shall not prevent access, at the discretion of
223	223	the Director of the Oklahoma State Bureau of Narcotics and Dangerous
224	224	Drugs Control, to investig ative information by peace officers and
225	225	investigative agents of federal, state, tribal, county or municipal
226	226	law enforcement agencies, district attorneys and the Attor ney
227	227	General in furtherance of crimin al, civil or administrative
228	228	investigations or prosecut ions within their respective
229	229	jurisdictions, designated legal, communicati ons, and analytical
230	230	employees of the Burea u, and to registrants in furtherance of
231	231	efforts to guard against the diversion of contr olled dangerous
232	232	substances.
233	233	C. This section shall not prevent the disclosure, at the
234	234	discretion of the Director of the Oklahom a State Bureau of Narcotics
235	235	and Dangerous Drugs Control, of statistical information gathered
236	236	from the central repository to the g eneral public for statistical,
237	237	research, substance abuse prevention, or educational purposes,
238	238	provided that consumer confidentiality is not compromised.
239	239
240	240
241	241	Req. No. 264 Page 4 1
242	242	2
243	243	3
244	244	4
245	245	5
246	246	6
247	247	7
248	248	8
249	249	9
250	250	10
251	251	11
252	252	12
253	253	13
254	254	14
255	255	15
256	256	16
257	257	17
258	258	18
259	259	19
260	260	20
261	261	21
262	262	22
263	263	23
264	264	24
265	265	1
266	266	2
267	267	3
268	268	4
269	269	5
270	270	6
271	271	7
272	272	8
273	273	9
274	274	10
275	275	11
276	276	12
277	277	13
278	278	14
279	279	15
280	280	16
281	281	17
282	282	18
283	283	19
284	284	20
285	285	21
286	286	22
287	287	23
288	288	24
289	289
290	290	D. This section shall not prevent the disclosure, at the
291	291	discretion of the Director of the Oklahoma State Bureau of Narcotics
292	292	and Dangerous Drugs Control, of prescription-monitoring-program
293	293	information to prescription-monitoring programs of other states
294	294	provided a reciprocal data-sharing agreement is in place.
295	295	E. The Department of Mental Health and Substance Abuse Services
296	296	and the State Department of Health ma y utilize the information in
297	297	the central repository for statistical, research, substance abuse
298	298	prevention, or educational purposes, provided that consumer
299	299	confidentiality is not compromised.
300	300	F. Any unauthorized disclosure of any information collected at
301	301	the central repository provided by the Anti -Drug Diversion Act shall
302	302	be a misdemeanor. Violation of the provisions of this section shall
303	303	be deemed willful neglect of duty and shall be grounds for removal
304	304	from office.
305	305	G. 1. a. Registrants shall have access t o the central
306	306	repository for the purposes of patien t treatment and
307	307	to aid in the determination in prescribing or
308	308	screening new patients. The physician or designee
309	309	shall provide, upon request by the patient, the
310	310	history of the patient or the query histor y of the
311	311	patient.
312	312
313	313
314	314	Req. No. 264 Page 5 1
315	315	2
316	316	3
317	317	4
318	318	5
319	319	6
320	320	7
321	321	8
322	322	9
323	323	10
324	324	11
325	325	12
326	326	13
327	327	14
328	328	15
329	329	16
330	330	17
331	331	18
332	332	19
333	333	20
334	334	21
335	335	22
336	336	23
337	337	24
338	338	1
339	339	2
340	340	3
341	341	4
342	342	5
343	343	6
344	344	7
345	345	8
346	346	9
347	347	10
348	348	11
349	349	12
350	350	13
351	351	14
352	352	15
353	353	16
354	354	17
355	355	18
356	356	19
357	357	20
358	358	21
359	359	22
360	360	23
361	361	24
362	362
363	363	b. (1) The Oklahoma State Bureau of Narcotics and
364	364	Dangerous Drugs Control shall establish
365	365	procedures by which a patient may:
366	366	(a) request and obtain his or her own controlled
367	367	substances history or, in appropriate
368	368	circumstances, that of a patient who l acks
369	369	capacity to make health care decisions and
370	370	for whom the individual has legal authority
371	371	to make such decisions and would have legal
372	372	access to the patient ’s health care records,
373	373	or
374	374	(b) seek review of any part of his or her
375	375	controlled substances history or, in
376	376	appropriate circumstances, that of a patient
377	377	who lacks capacity to make health care
378	378	decisions and for whom the individual has
379	379	legal authority to make such decisions and
380	380	would have legal access to the patient ’s
381	381	health care records, that such individual
382	382	disputes.
383	383	(2) Such procedures shall require the Bureau to
384	384	promptly revise any information accessible
385	385	through the central repository that the Bureau
386	386	determines to be inaccurate. Such procedures
387	387
388	388
389	389	Req. No. 264 Page 6 1
390	390	2
391	391	3
392	392	4
393	393	5
394	394	6
395	395	7
396	396	8
397	397	9
398	398	10
399	399	11
400	400	12
401	401	13
402	402	14
403	403	15
404	404	16
405	405	17
406	406	18
407	407	19
408	408	20
409	409	21
410	410	22
411	411	23
412	412	24
413	413	1
414	414	2
415	415	3
416	416	4
417	417	5
418	418	6
419	419	7
420	420	8
421	421	9
422	422	10
423	423	11
424	424	12
425	425	13
426	426	14
427	427	15
428	428	16
429	429	17
430	430	18
431	431	19
432	432	20
433	433	21
434	434	22
435	435	23
436	436	24
437	437
438	438	shall be described on the Bureau’s website and
439	439	included with the con trolled substances history
440	440	provided to an individua l pursuant to a request
441	441	made under this subparagraph.
442	442	2. a. Prior to prescribing or autho rizing for refill, if one
443	443	hundred eighty (180) days have elapse d prior to the
444	444	previous access and check, of opiates, synthetic
445	445	opiates, semisynthetic opiates, benzodia zepine or
446	446	carisoprodol to a patient of record, registrants or
447	447	members of their medical or administrative staff shall
448	448	be required to access the informati on in the central
449	449	repository to assess medical necessity and the
450	450	possibility that the patient may be unl awfully
451	451	obtaining prescription drug s in violation of the
452	452	Uniform Controlled Dangerous Sub stances Act. The duty
453	453	to access and check shall not alter or o therwise amend
454	454	appropriate medical standards of care. The registrant
455	455	or medical provider shall note in the patient file
456	456	that the central repository has been checked and may
457	457	maintain a copy of the information.
458	458	b. The requirements set forth in subparagraph a of this
459	459	paragraph shall not apply:
460	460	(1) to medical practitioners who prescribe the
461	461	controlled substance s set forth in subparagraph a
462	462
463	463
464	464	Req. No. 264 Page 7 1
465	465	2
466	466	3
467	467	4
468	468	5
469	469	6
470	470	7
471	471	8
472	472	9
473	473	10
474	474	11
475	475	12
476	476	13
477	477	14
478	478	15
479	479	16
480	480	17
481	481	18
482	482	19
483	483	20
484	484	21
485	485	22
486	486	23
487	487	24
488	488	1
489	489	2
490	490	3
491	491	4
492	492	5
493	493	6
494	494	7
495	495	8
496	496	9
497	497	10
498	498	11
499	499	12
500	500	13
501	501	14
502	502	15
503	503	16
504	504	17
505	505	18
506	506	19
507	507	20
508	508	21
509	509	22
510	510	23
511	511	24
512	512
513	513	of this paragraph for hospice or end-of-life
514	514	care, or
515	515	(2) for a prescription of a controlled s ubstance set
516	516	forth in subparagraph a of this paragraph that is
517	517	issued by a practitioner for a patient residing
518	518	in a nursing facility as defined by Section 1-
519	519	1902 of this title, provided that the
520	520	prescription is issued to a resident of such
521	521	facility.
522	522	3. Registrants shall not be l iable to any person for any cla im
523	523	of damages as a result of accessing or failing to access the
524	524	information in the central repository and no lawsuit may be
525	525	predicated thereon.
526	526	4. The failure of a r egistrant to access and check the c entral
527	527	repository as required under state or federal la w or regulation may,
528	528	after investigation, be grounds for the licensing boar d of the
529	529	registrant to take disc iplinary action against the registrant.
530	530	H. The Board of Podiatric Medical Examiners, the Board of
531	531	Dentistry, the State Board of Medical Licensure and Supervision, the
532	532	Board of Examiners in Optometry, the Oklahoma Board of Nursing, the
533	533	State Board of Osteopathic Examiners and the State Board of
534	534	Veterinary Medical Examiners sh all have the sole responsibility for
535	535	enforcement of the pro visions of subsection G of this section.
536	536	Nothing in this section shall be construed s o as to permit the
537	537
538	538
539	539	Req. No. 264 Page 8 1
540	540	2
541	541	3
542	542	4
543	543	5
544	544	6
545	545	7
546	546	8
547	547	9
548	548	10
549	549	11
550	550	12
551	551	13
552	552	14
553	553	15
554	554	16
555	555	17
556	556	18
557	557	19
558	558	20
559	559	21
560	560	22
561	561	23
562	562	24
563	563	1
564	564	2
565	565	3
566	566	4
567	567	5
568	568	6
569	569	7
570	570	8
571	571	9
572	572	10
573	573	11
574	574	12
575	575	13
576	576	14
577	577	15
578	578	16
579	579	17
580	580	18
581	581	19
582	582	20
583	583	21
584	584	22
585	585	23
586	586	24
587	587
588	588	Director of the State Bureau of Narcot ics and Dangerous Drugs
589	589	Control to assess administrati ve fines provided for in Section 2-304
590	590	of this title.
591	591	I. The Director of the Oklahoma State Bureau of Narcotics and
592	592	Dangerous Drugs Control, or a designee thereof, shall provide a
593	593	monthly list to the D irectors of the Board of Podiatric Medical
594	594	Examiners, the Board of Dentistry, the State Board of Medi cal
595	595	Licensure and Supervision, the Board of Examiners in Optometry, the
596	596	Oklahoma Board of Nursing, the State Board of Osteopathic Examiners
597	597	and the State Board of Veterinary Medical Examiners of the top
598	598	twenty prescribers of controlled dangerous substances within their
599	599	respective areas of jurisdiction. Upon dis covering that a
600	600	registrant is prescribing outside the limitations of his or her
601	601	licensure or outside of drug registration rules or applicable state
602	602	laws, the respective licensing board shall be notified by the Bureau
603	603	in writing. Such notifications may be considered complaints for the
604	604	purpose of investigations or other actions by the respect ive
605	605	licensing board. Licensing boards shall have exclusive jurisdiction
606	606	to take action against a licensee for a violation of subsection G of
607	607	this section.
608	608	J. Information regarding fatal and non fatal overdoses, other
609	609	than statistical information as requir ed by Section 2-106 of this
610	610	title, shall be completely confidential. Access to this information
611	611	shall be strictly limited to the Director of the Oklahoma State
612	612
613	613
614	614	Req. No. 264 Page 9 1
615	615	2
616	616	3
617	617	4
618	618	5
619	619	6
620	620	7
621	621	8
622	622	9
623	623	10
624	624	11
625	625	12
626	626	13
627	627	14
628	628	15
629	629	16
630	630	17
631	631	18
632	632	19
633	633	20
634	634	21
635	635	22
636	636	23
637	637	24
638	638	1
639	639	2
640	640	3
641	641	4
642	642	5
643	643	6
644	644	7
645	645	8
646	646	9
647	647	10
648	648	11
649	649	12
650	650	13
651	651	14
652	652	15
653	653	16
654	654	17
655	655	18
656	656	19
657	657	20
658	658	21
659	659	22
660	660	23
661	661	24
662	662
663	663	Bureau of Narcotics and Dangerous Drugs Control or designee, the
664	664	Chief Medical Examiner, state agencies and boards pr ovided in
665	665	subsection A of this section, and the registrant that enters the
666	666	information. Registrants shall not be liable to any person for a
667	667	claim of damages for information reported pursuant to the provisions
668	668	of Section 2-105 of this title.
669	669	K. The Director of the Oklahoma State Bureau of Narcotics and
670	670	Dangerous Drugs Control shall provide adequate means and procedures
671	671	allowing access to central rep ository information for re gistrants
672	672	lacking direct computer access.
673	673	L. Upon completion of an investigation i n which it is
674	674	determined that a death was caused by an overdose, either
675	675	intentionally or unintentionally, of a controlled da ngerous
676	676	substance, the medical examiner shall be required to report the
677	677	decedent’s name and date of birth to t he Oklahoma State Bure au of
678	678	Narcotics and Dangerous Drugs Control. The Oklahoma State Bureau of
679	679	Narcotics and Dangerous Drugs Control shall be re quired to maintain
680	680	a database containing the clas sification of medical practitioners
681	681	who prescribed or authori zed controlled dangero us substances
682	682	pursuant to this subsection.
683	683	M. The Oklahoma State Bureau of Narcotics and Dangerous Drugs
684	684	Control is authorized to provide unsolici ted notification to the
685	685	licensing board of a pharmacist or practitioner if a patient ha s
686	686	received one or more prescriptions for controlled substances in
687	687
688	688
689	689	Req. No. 264 Page 10 1
690	690	2
691	691	3
692	692	4
693	693	5
694	694	6
695	695	7
696	696	8
697	697	9
698	698	10
699	699	11
700	700	12
701	701	13
702	702	14
703	703	15
704	704	16
705	705	17
706	706	18
707	707	19
708	708	20
709	709	21
710	710	22
711	711	23
712	712	24
713	713	1
714	714	2
715	715	3
716	716	4
717	717	5
718	718	6
719	719	7
720	720	8
721	721	9
722	722	10
723	723	11
724	724	12
725	725	13
726	726	14
727	727	15
728	728	16
729	729	17
730	730	18
731	731	19
732	732	20
733	733	21
734	734	22
735	735	23
736	736	24
737	737
738	738	quantities or with a frequency inconsistent with generally
739	739	recognized standards of safe practice. An unsolicited notification
740	740	to the licensing board of the practitioner pursuant to this sec tion:
741	741	1. Is confidential;
742	742	2. May not disclose information that is confidential pursuant
743	743	to this section; and
744	744	3. May be in a summary form suffic ient to provide notice of the
745	745	basis for the unsoli cited notification.
746	746	N. Except as otherwise provide d for in subsections A and B of
747	747	this section, any information collected at the central repository,
748	748	as outlined in Section 2-309C of this title, shall:
749	749	1. Be confidential by law and privileged;
750	750	2. Not be subject to the Oklahoma Open Records Act;
751	751	3. Not be subject to subpoena; and
752	752	4. Not be subject to discovery or admissible in evide nce in any
753	753	private civil action.
754	754	SECTION 2. This act shall become effective Nove mber 1, 2023.
755	755
756	756	59-1-264 DC 1/12/2023 1:42:24 PM

Oklahoma 2023 Regular Session

Oklahoma Senate Bill SB295 Compare Versions